Mark Clein is the founder of Precision Medicine Group. Precision Medicine Group has raised $310M in total funding. Latest round: Growth.
Mark Clein is the Co-Founder and former Chief Executive Officer of Precision Medicine Group, a Bethesda, Maryland-based company. He transitioned from the CEO role to Executive Chairman in 2024, at which point Margaret Keegan became CEO. Clein remains a Co-Founder and is listed as an individual angel investor associated with the company's seed stage activities.
Full founder directory · Investor directory · Company funding database · Fundraising library